Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

491.70 +1.72 (+0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier. 
Via Investor's Business Daily
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps. 
Via Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better. 
Via Investor's Business Daily
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
What Does IDEXX Laboratories' Debt Look Like?
Shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) moved higher by 28.56% in the past three months. Before having a look at the importance of debt, let's look at how much debt IDEXX Laboratories has. 
Via Benzinga
Golden Cross Appears Before IDEXX Laboratories Investors
Via Benzinga
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know
Via Benzinga
Why IDEXX Stock Popped Today
The animal healthcare company beat estimates on the top and bottom lines. 
Via The Motley Fool
Where IDEXX Laboratories Stands With Analysts
Analysts have provided the following ratings for IDEXX Laboratories (NASDAQ:IDXX) within the last quarter: 
Via Benzinga
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023
By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her. 
Via The Motley Fool
Looking Into IDEXX Laboratories's Return On Capital Employed
Pulled from Benzinga Pro data, IDEXX Laboratories (NASDAQ:IDXX) posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million, a 2.19% decrease between... 
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
The 3 Best Pet Stocks to Buy Now
Pets are a big part of the family in America, and that trend is only growing. Here are some top pet stocks to help you profit from the trend. 
Via InvestorPlace
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
IDEXX Laboratories: Q3 Earnings Insights
IDEXX Laboratories (NASDAQ:IDXX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Peering Into IDEXX Laboratories's Recent Short Interest
IDEXX Laboratories's (NASDAQ:IDXX) short percent of float has risen 14.54% since its last report. The company recently reported that it has 2.37 million shares sold short, which is 3.23% of all regular... 
Via Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 12.17% on an annualized basis producing an average annual return of 22.65%. Currently, IDEXX Laboratories has a... 
Via Benzinga
Expert Ratings for IDEXX Laboratories
Over the past 3 months, 7 analysts have published their opinion on IDEXX Laboratories (NASDAQ:IDXX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Don’t Miss the Turnaround in These 3 Stocks
Of the 48 companies down more than double the S&P 500 year-to-date, these are the three stocks to buy for a turnaround in 2023. 
Via InvestorPlace
Recap: IDEXX Laboratories Q2 Earnings
  IDEXX Laboratories (NASDAQ:IDXX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 1.93% on an annualized basis producing an average annual return of 9.0%. Currently, IDEXX Laboratories has a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
Upgrades 
Via Benzinga
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022
Upgrades 
Via Benzinga
7 Wildly Oversold S&P 500 Stocks to Buy Now
These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound. 
Via InvestorPlace
$1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 5.54% on an annualized basis producing an average annual return of 13.53%. Currently, IDEXX Laboratories has a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
IDEXX Laboratories's (NASDAQ:IDXX) short percent of float has risen 7.34% since its last report. The company recently reported that it has 1.95 million shares sold short, which is... 
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.